200134-22-1 - Names and Identifiers
200134-22-1 - Physico-chemical Properties
Molecular Formula | C15H16N2O
|
Molar Mass | 240.3 |
Density | 1.185±0.06 g/cm3(Predicted) |
Boling Point | 296.4±19.0 °C(Predicted) |
Solubility | soluble in DMSO |
pKa | 14.46±0.70(Predicted) |
Storage Condition | Sealed in dry,Room Temperature |
Use | INH14 is an inhibitor of IKKα/IKKβ with IC50 values of 8.97 and 3.59 μM, respectively. INH14 inhibits the IKKα/β-dependent TLR inflammatory response. Inhibit the downstream and NF-kB signaling pathways of TAK1/TAB1. It has anti-inflammatory and anti-cancer effects. |
200134-22-1 - Preparation solution concentration reference
| 1mg | 5mg | 10mg |
---|
1 mM | 4.161 ml | 20.807 ml | 41.615 ml |
5 mM | 0.832 ml | 4.161 ml | 8.323 ml |
10 mM | 0.416 ml | 2.081 ml | 4.161 ml |
5 mM | 0.083 ml | 0.416 ml | 0.832 ml |
Last Update:2024-01-02 23:10:35
200134-22-1 - Reference Information
biological activity | INH14 is an inhibitor of TLR2-mediated NF-kB activation, the IC50 values for ikkα and IKKβ were 8.975 μm and 3.598 μm, respectively. |
Target | Value |
NF-κB
()
| |
IKKβ
()
| 3.598 μM |
IKKα
()
| 8.975 μM |
Animal Model:
| 8-week old, male, pathogen-free C57BL/6J mice |
Dosage:
| 5 µg/g, one hour before Pam2CSK4 injection |
Administration:
| I.P. for 2 hours |
Result:
| Decreased TNFα production in mice. |
Last Update:2024-04-10 22:29:15